Cambrian Genomics
San Francisco, US · Founded 2011 · 1 known investors
Founders & leadership
RJ
Reese JonesNamed on SEC filing
AH
Austen HeinzNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$11.2M disclosed across 1 round · 2014
▶$11.2MraisedDec 2014 · 109 investors · OtherRule 506(b)
▶$11.2MraisedDec 2014 · 109 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Reese JonesDirector
- Austen HeinzExecutive Officer, Director
- Offering amount
- $12.5M
- Amount sold
- $11.2M
- Minimum investment
- $1
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2013 | $150K |
| Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects Agency | Phase I | 2013 | $99.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who are Cambrian Genomics's investors?
- Cambrian Genomics's investors include MI Ventures.
- How much funding has Cambrian Genomics raised?
- Cambrian Genomics has disclosed $11.2M raised across 1 round.
- Where is Cambrian Genomics headquartered?
- Cambrian Genomics is headquartered in San Francisco, US.